TANDEM DIABETES CARE INC
▲ 1 upgrades / ▼ 0 downgrades / 1 reiterations from 2 firms
Nov 5, 2026 (10 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 7, 2026 | Barclays | initiate | — → Equal-Weight | — | 53% |
| Sep 30, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Sep 24, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Aug 21, 2026 | William Blair | initiate | — → Outperform | — | 48% |
| Aug 7, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Aug 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 15, 2026 | Mizuho | maintain | Neutral → Neutral | — | 52% |
| Jun 23, 2026 | Deutsche Bank | initiate | Buy → Hold | — | 57% |
| Jun 1, 2026 | Wells Fargo | upgrade | Equal-Weight → Overweight | — | 54% |
| May 28, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| May 18, 2026 | B of A Securities | maintain | Neutral → Neutral | — | 53% |
| May 12, 2026 | Benchmark | initiate | — → Hold | — | 54% |
| May 11, 2026 | Truist Securities | reiterate | Buy → Buy | — | 54% |
| May 11, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 20, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Apr 9, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Mar 19, 2026 | Truist Securities | upgrade | Hold → Buy | — | 54% |
| Mar 17, 2026 | Piper Sandler | upgrade | Neutral → Overweight | — | 54% |
| Mar 2, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Feb 23, 2026 | Lake Street | upgrade | Hold → Buy | $50 | 47% |
| Feb 23, 2026 | Truist Securities | reiterate | Hold → Hold | $27 | 54% |
| Feb 20, 2026 | Mizuho | maintain | Neutral → Neutral | $22 | 52% |
| Feb 20, 2026 | UBS | maintain | Neutral → Neutral | $22 | 54% |
| Feb 20, 2026 | Stifel | maintain | Hold → Hold | $22 | 53% |
| Feb 20, 2026 | B of A Securities | upgrade | Underperform → Neutral | $30 | 53% |
| Feb 20, 2026 | Piper Sandler | maintain | Neutral → Neutral | $21 | 54% |
| Feb 4, 2026 | Stifel | maintain | Hold → Hold | $20 | 53% |
| Jan 9, 2026 | Bernstein | maintain | Market Perform → Market Perform | $25 | 52% |
| Dec 18, 2025 | Truist Securities | maintain | Hold → Hold | $24 | 54% |
| Dec 17, 2025 | Canaccord Genuity | maintain | Buy → Buy | $35 | 48% |
| Dec 17, 2025 | Mizuho | maintain | Neutral → Neutral | $21 | 52% |
| Dec 16, 2025 | Baird | upgrade | Neutral → Outperform | $30 | 55% |
| Dec 11, 2025 | Citigroup | maintain | Neutral → Neutral | $22 | 54% |
| Dec 2, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $23 | 54% |
| Nov 10, 2025 | Barclays | maintain | Overweight → Overweight | $55 | 53% |
| Nov 10, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $17 | 54% |
| Nov 10, 2025 | Truist Securities | reiterate | Hold → Hold | $17 | 54% |
| Nov 7, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $14 | 54% |
| Oct 15, 2025 | Truist Securities | maintain | Hold → Hold | $16 | 54% |
| Oct 7, 2025 | Citigroup | maintain | Neutral → Neutral | $15 | 54% |
| Sep 29, 2025 | Canaccord Genuity | maintain | Buy → Buy | $24 | 48% |
| Sep 8, 2025 | Oppenheimer | maintain | Outperform → Outperform | $22 | 52% |
| Aug 21, 2025 | Citigroup | maintain | Neutral → Neutral | $11 | 54% |
| Aug 12, 2025 | Citigroup | upgrade | Sell → Neutral | $10.35 | 54% |
| Aug 11, 2025 | Lake Street | downgrade | Buy → Hold | $12 | 47% |
| Aug 8, 2025 | Barclays | maintain | Overweight → Overweight | $51 | 53% |
| Aug 7, 2025 | Canaccord Genuity | maintain | Buy → Buy | $24 | 48% |
| Aug 7, 2025 | UBS | maintain | Neutral → Neutral | $17 | 54% |
| Aug 7, 2025 | RBC Capital | maintain | Outperform → Outperform | $25 | 55% |
| Aug 7, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $13 | 54% |
No cross-platform signals in the last 90 days